Cargando…

Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models

Airway inflammation is crucial in the pathogenesis of many respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma. Current evidence supports the beneficial impact of muscarinic receptor antagonists against airway inflammation from bench-to-bedside. Considering the nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calzetta, Luigino, Pistocchini, Elena, Ritondo, Beatrice Ludovica, Cavalli, Francesco, Camardelli, Francesca, Rogliani, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240991/ https://www.ncbi.nlm.nih.gov/pubmed/35785239 http://dx.doi.org/10.1016/j.heliyon.2022.e09760

Ejemplares similares

The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review
por: Calzetta, Luigino, et al.
Publicado: (2021)

The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
por: Calzetta, Luigino, et al.
Publicado: (2022)

Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis
por: Calzetta, Luigino, et al.
Publicado: (2022)

Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma
por: Calzetta, Luigino, et al.
Publicado: (2022)

Sex differences in adult asthma and COPD therapy: a systematic review
por: Rogliani, Paola, et al.
Publicado: (2022)

The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review
por: Calzetta, Luigino, et al.
Publicado: (2022)

Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration
por: Ritondo, Beatrice Ludovica, et al.
Publicado: (2020)

The Impact of Monoclonal Antibodies on Airway Smooth Muscle Contractility in Asthma: A Systematic Review
por: Calzetta, Luigino, et al.
Publicado: (2021)

Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review
por: Rogliani, Paola, et al.
Publicado: (2020)

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
por: Ora, Josuel, et al.
Publicado: (2020)

Drug interaction and chronic obstructive respiratory disorders
por: Rogliani, Paola, et al.
Publicado: (2020)

Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations
por: Calzetta, Luigino, et al.
Publicado: (2020)

Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials
por: Calzetta, Luigino, et al.
Publicado: (2021)

Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis
por: Calzetta, Luigino, et al.
Publicado: (2022)

Severe Asthma and Biological Therapy: When, Which, and for Whom
por: Rogliani, Paola, et al.
Publicado: (2019)

Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens
por: Liccardi, Gennaro, et al.
Publicado: (2016)

Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
por: Cazzola, Mario, et al.
Publicado: (2023)

Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies
por: Rogliani, Paola, et al.
Publicado: (2022)

Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine
por: Calzetta, Luigino, et al.
Publicado: (2017)

Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells
por: Cazzola, Mario, et al.
Publicado: (2016)

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
por: Calzetta, Luigino, et al.
Publicado: (2018)

Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients
por: Calzetta, Luigino, et al.
Publicado: (2019)

Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
por: Matera, Maria Gabriella, et al.
Publicado: (2020)

Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
por: Rogliani, Paola, et al.
Publicado: (2022)

Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score
por: Rogliani, Paola, et al.
Publicado: (2022)

Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation
por: Cazzola, Mario, et al.
Publicado: (2017)

Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives
por: Cazzola, Mario, et al.
Publicado: (2021)

Mortality in ETHOS: A Question of “Power”
por: Rogliani, Paola, et al.
Publicado: (2021)

Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
por: Calzetta, Luigino, et al.
Publicado: (2022)

Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
por: Cazzola, Mario, et al.
Publicado: (2023)

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease()
por: Dale, Philippa R, et al.
Publicado: (2014)

The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β(2) Adrenergic Receptor Agonist Navafenterol in Human Small Airways
por: Jude, Joseph Antony, et al.
Publicado: (2023)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines
por: Rogliani, Paola, et al.
Publicado: (2021)

Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor
por: Buigues, Pedro J., et al.
Publicado: (2023)

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
por: Cazzola, Mario, et al.
Publicado: (2020)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

The clinical use of regenerative therapy in COPD
por: Lipsi, Roberto, et al.
Publicado: (2014)

Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
por: Principe, Stefania, et al.
Publicado: (2019)

Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
por: Calzetta, Luigino, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vra4r40sd7a049huba1thbak0l